Antoon B.
- Country
- Belgium
- Department
- Gastro-enterology
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 2 Randomized Study of Neoadjuvant Dostarlimab Plus CAPEOX Versus CAPEOX in T4N0 or Stage III MMRp/MSS Colon Cancer Patients
Data & Insights
Has run more than one trial at 6 of 123 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment of colorectal cancer, with particular emphasis on colon cancer management and innovative therapeutic approaches.
- Advanced Colon Cancer Treatment
- Neoadjuvant Therapy Strategies
- Gastrointestinal Malignancies
Key focus includes treating patients with MMRp/MSS colon cancer and exploring combination therapy approaches.
Precision Medicine
Demonstrates expertise in molecular profiling and targeted treatment strategies for gastrointestinal cancers.
- Biomarker-Driven Therapy
- Personalized Treatment Approaches
- Molecular Classification
Specializes in treatment selection based on specific molecular characteristics of colorectal tumors.
Combined Modality Treatment
Focuses on integrating different therapeutic modalities for optimal patient outcomes in gastrointestinal oncology.
- Chemotherapy Combinations
- Immunotherapy Integration
- Treatment Sequencing
Expertise in combining systemic therapies for advanced-stage colorectal cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.